T. Rowe Price Funds SICAV - China Evolution Equity Fund A |
Performance History | 28/02/2025 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | 3.8 | -16.5 | -20.9 | 12.4 | 2.9 |
![]() | +/-Cat | 18.6 | -0.7 | -0.5 | -1.9 | -6.6 |
![]() | +/-B’mrk | 24.9 | -6.1 | -5.8 | -7.5 | -9.1 |
Category: China Equity | ||||||
Category Benchmark: Morningstar China TME NR USD |
Key Stats | ||
NAV 01/04/2025 | USD 8.69 | |
Day Change | 0.45% | |
Morningstar Category™ | China Equity | |
ISIN | LU2187417386 | |
Fund Size (Mil) 01/04/2025 | USD 202.50 | |
Share Class Size (Mil) 01/04/2025 | USD 19.32 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 17/02/2025 | 1.87% |
Investment Objective: T. Rowe Price Funds SICAV - China Evolution Equity Fund A |
To increase the value of its shares, over the long term, through growth in the value of its investments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Wenli Zheng 10/08/2020 | ||
Inception Date 10/08/2020 |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI China All Shares NR USD | Morningstar China TME NR USD |
Portfolio Profile for T. Rowe Price Funds SICAV - China Evolution Equity Fund A | 28/02/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 5.29 |
![]() | ![]() | 3.31 |
![]() | ![]() | 2.98 |
![]() | ![]() | 2.76 |
![]() | ![]() | 2.72 |
![]() | ||
![]() ![]() ![]() | ||
T. Rowe Price Funds SICAV - China Evolution Equity Fund A |
Growth Of 1000 (GBP) | 28/02/2025 |
|
Annual Returns (GBP) | 28/02/2025 | |||||||
2021 | 2022 | 2023 | 2024 | 28/02 | ||||
Price Return | 3.80 | -16.45 | -20.92 | 12.38 | 2.87 | |||
+/- Category | 18.61 | -0.67 | -0.54 | -1.92 | -6.56 | |||
+/- Category Index | 24.90 | -6.06 | -5.84 | -7.48 | -9.07 | |||
% Rank in Category | 4 | 56 | 52 | 59 | 93 |
Trailing Returns (GBP) | 01/04/2025 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.45 | 1.57 | -0.10 |
1 Week | 0.64 | 3.35 | 0.94 |
1 Month | 0.19 | 1.39 | 0.26 |
3 Months | 3.07 | -5.22 | -8.80 |
6 Months | -0.95 | -8.07 | -9.02 |
YTD | 3.07 | -5.22 | -8.80 |
1 Year | 11.00 | -14.40 | -23.55 |
3 Years Annualised | -2.67 | -1.73 | -6.59 |
5 Years Annualised | - | - | - |
10 Years Annualised | - | - | - |
Category: China Equity | |||
Category Index: Morningstar China TME NR USD |
Quarterly Returns (GBP) | 28/02/2025 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.78 | 5.45 | 5.86 | -2.99 |
2023 | -0.29 | -12.63 | -1.86 | -7.50 |
2022 | -18.31 | 13.69 | -11.30 | 1.41 |
2021 | 6.95 | 3.47 | -6.02 | -0.20 |
2020 | - | - | - | 10.87 |
Morningstar Rating™(Relative to Category) | 28/02/2025 | ||||||||||||||||||||
| |||||||||||||||||||||
Category : China Equity | Click here to see our Methodology |
Volatility Measurements | 28/02/2025 | ||||||||||
| |||||||||||
Modern Portfolio Statistics | 28/02/2025 | 28/02/2025 |
Standard Index | Best Fit Index | |
Morningstar China TME NR USD | Morningstar China TME NR USD | |
3-Yr Beta | 0.85 | 0.85 |
3-Yr Alpha | -9.23 | -9.23 |
Investment Style Details | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Category: China Equity |
Asset Allocation | 28/02/2025 |
|
World Regions | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Category: China Equity |
Sector Weightings | 28/02/2025 | ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
Category: China Equity |
Top 10 Holdings | 28/02/2025 |
Portfolio NEW | |
Total Number of Equity Holdings | 59 |
Total Number of Bond Holdings | 0 |
Assets in Top 10 Holdings | 29.82 |
Name | Sector | Country | % of Assets | ||
![]() | ![]() | China | 5.29 | ||
![]() | ![]() | China | 3.31 | ||
![]() | ![]() | China | 2.98 | ||
![]() | ![]() | China | 2.76 | ||
![]() | ![]() | China | 2.72 | ||
![]() | ![]() | China | 2.72 | ||
![]() | ![]() | China | 2.55 | ||
![]() | ![]() | China | 2.52 | ||
![]() | ![]() | China | 2.51 | ||
![]() | ![]() | China | 2.46 | ||
![]() ![]() ![]() | |||||
Category: China Equity | |||||
Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
![]() | |
Biography | |
Wenli Zheng has been chairman of the committee since 2019. He joined the Firm in 2008 and his investment experience dates from that time. Wenli completed an internship at T. Rowe Price in 2007 and has been with the firm since 2008. Prior to joining T. Rowe Price, he was a strategy consultant at Capgemini in China. Wenli earned an M.B.A. from the University of Chicago and a dual bachelor's degree in industrial engineering and economics from the South China University of Technology. |
Fees and Expenses | ||||||||||||
|
Purchase Details | ||||||||
| ||||||||
|